Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 8.25 is 45% below its 5-year average of 14.90, around the middle of its 5-year range (-121.79–142.61).
144.01% above its 12-month average of -18.74.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
8.25
EARNINGS PER SHARE (EPS) AVG TTM
-18.74
EARNINGS PER SHARE (EPS) AVG 3Y
-45.28
EARNINGS PER SHARE (EPS) AVG 5Y
14.90
EARNINGS PER SHARE (EPS) AVG 10Y
15.38
EARNINGS PER SHARE (EPS) AVG 15Y
7.35
EARNINGS PER SHARE (EPS) AVG 20Y
4.62
CURRENT VS TTM AVG
+144.01%
CURRENT VS 3Y AVG
+118.22%
CURRENT VS 5Y AVG
-44.61%
CURRENT VS 10Y AVG
-46.35%
CURRENT VS 15Y AVG
+12.32%
CURRENT VS 20Y AVG
+78.54%
Bio-Rad Laboratories, Inc.
Market Cap
$10.07B
Earnings Per Share (EPS)
8.25
TTM Avg
-18.74
3Y Avg
-45.28
5Y Avg
14.90
Market Cap
$10.03B
Earnings Per Share (EPS)
3.43
TTM Avg
3.18
3Y Avg
3.37
5Y Avg
3.47
Market Cap
$10.15B
Earnings Per Share (EPS)
3.89
TTM Avg
2.37
3Y Avg
1.93
5Y Avg
1.71
Market Cap
$9.89B
Earnings Per Share (EPS)
0.19
TTM Avg
14.72
3Y Avg
15.46
5Y Avg
14.11
Market Cap
$10.32B
Earnings Per Share (EPS)
24.38
TTM Avg
20.29
3Y Avg
15.04
5Y Avg
13.87
Market Cap
$9.81B
Earnings Per Share (EPS)
6.38
TTM Avg
5.63
3Y Avg
4.78
5Y Avg
4.31
Market Cap
$10.89B
Earnings Per Share (EPS)
5.76
TTM Avg
5.64
3Y Avg
5.43
5Y Avg
9.01
Market Cap
$10.98B
Earnings Per Share (EPS)
-1.44
TTM Avg
-3.00
3Y Avg
-2.43
5Y Avg
-2.16
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | $10.07B | 8.25 | -18.74 | -45.28 | 14.90 |
| Henry Schein, Inc. (HSIC)vs › | $10.03B | 3.43 | 3.18 | 3.37 | 3.47 |
| Globus Medical, Inc. (GMED)vs › | $10.15B | 3.89 | 2.37 | 1.93 | 1.71 |
| Molina Healthcare, Inc. (MOH)vs › | $9.89B | 0.19 | 14.72 | 15.46 | 14.11 |
| Universal Health Services, Inc. (UHS)vs › | $10.32B | 24.38 | 20.29 | 15.04 | 13.87 |
| The Ensign Group, Inc. (ENSG)vs › | $9.81B | 6.38 | 5.63 | 4.78 | 4.31 |
| Insulet Corp. (PODD)vs › | $9.74B | 5.35 | 4.74 | 3.13 | 2.14 |
| Align Technology, Inc. (ALGN)vs › | $10.89B | 5.76 | 5.64 | 5.43 | 9.01 |
| Tempus AI, Inc. (TEM)vs › | $10.98B | -1.44 | -3.00 | -2.43 | -2.16 |
| Bio-Techne Corporation (TECH)vs › | $11.31B | 1.16 | 0.82 | 1.13 | 1.19 |
Trailing EPS (TTM)
$8.25
Forward EPS (Est.)
$9.64
P/E Ratio
46.1
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 27.87 |
| 2024-12-31 | -65.36 |
| 2023-12-31 | -21.82 |
| 2022-12-31 | -121.79 |
| 2021-12-31 | 142.61 |
| 2020-12-31 | 127.86 |
| 2019-12-31 | 58.93 |
| 2018-12-31 | 12.10 |
| 2017-12-31 | 4.12 |
| 2016-12-31 | 0.88 |
| 2015-12-31 | 3.74 |
| 2014-12-31 | 3.08 |
| 2013-12-31 | 2.72 |
| 2012-12-31 | 5.85 |
| 2011-12-31 | 6.39 |
| 2010-12-31 | 6.70 |
| 2009-12-31 | 5.28 |
| 2008-12-31 | 3.30 |
| 2007-12-31 | 3.48 |
| 2006-12-31 | 3.92 |
| 2005-12-31 | 3.13 |
| 2004-12-31 | 2.65 |
| 2003-12-31 | 3.00 |
| 2002-12-31 | 2.70 |
| 2001-12-31 | 1.79 |
| 2000-12-31 | 1.27 |
| 1999-12-31 | 0.49 |
| 1998-12-31 | 0.99 |
| 1997-12-31 | 0.67 |
| 1996-12-31 | 1.07 |
Reported annual fiscal-period values; no daily interpolation.